Researchers validated a Japanese version of the ATTARI-12 scale to measure medical trainees' attitudes toward AI in healthcare.
Key Details
- 1The J-ATTARI-12 scale was developed and validated based on a nationwide survey of 326 Japanese medical students and residents.
- 2The scale assesses two dimensions: 'AI anxiety and aversion' and 'AI optimism and acceptance.'
- 3Psychometric evaluation showed good validity, reliability, and model fit.
- 4The tool enables structured assessment of readiness, concerns, and acceptance of AI in medical training.
- 5J-ATTARI-12 will be used in a new 'Medicine and AI' program at Juntendo University from 2026.
- 6Published in JMIR Medical Education on January 14, 2026.
Why It Matters
Understanding medical trainees’ attitudes toward AI is critical for effective curriculum development and the responsible integration of AI into clinical practice. The J-ATTARI-12 scale provides a culturally adapted tool to identify barriers and support the future workforce in adopting AI, including in radiology.
Source
EurekAlert
Related News
•EurekAlert
FDA Approves Johns Hopkins AI Tool for Early Sepsis Detection
FDA clears an AI-driven system developed by Johns Hopkins to detect sepsis up to 48 hours earlier and reduce mortality rates.
•EurekAlert
New AI Vision-Language Model Enhances Chest CT Diagnostics
Researchers developed an interpretable AI model that uses visual question answering to generate detailed diagnostic findings from chest CT scans, aimed at improving lung cancer diagnosis.
•EurekAlert
Optical AI Chip Boosts Real-Time Dry Eye Gland Diagnosis Accuracy
A new metasurface spectral AI chip enables rapid, accurate diagnosis of meibomian gland dysfunction (MGD) from tissue samples, achieving 96.22% accuracy.